HOME
NEWS & RESOURCES
CLINICAL TRIALS
RESEARCHER
More
Supported browsers: Edge, Chrome, and Safari
Vancomycin for Primary Sclerosing Cholangitis - The purpose is to assess the effects of different oral vancomycin doses on the clinical and biochemical course in adult patients with PSC.Phase 2 Study
PSC PARTNERS HOMEPAGE
Established in collaboration with the Office of Rare Diseases Research (ORDR), National Center for Advancing Translation Science (NCATS), and the National Institutes of Health
© PSC Partners Seeking a Cure - 2024, a 501(c)(3) organization. All rights reserved.